Kisqali 400 MG daily dose 42S
Ended Awarded
- Contract number
- SPE2DR26FXQ1T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,139
Award facts
- Contract value 100% obligated
- $18,138.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,138.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Kisqali 400 mg daily dose in quantities of 42 units. The contract, which represents a non-competitive set-aside award, is scheduled for completion by December 9, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Kisqali (ribociclib) is a cyclin-dependent kinase inhibitor used in oncology treatment, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing procurement of specialized pharmaceutical products to support military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion vehicle extending through December 2026 that serves as a comprehensive global pharmaceutical support program. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal contract awards encompassing a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains. The company's status as a child contract under this larger IDC vehicle demonstrates its ongoing role as a primary supplier for federal military healthcare procurement needs.
Quick answers
Who was awarded contract SPE2DR26FXQ1T?
SPE2DR26FXQ1T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FXQ1T worth?
The government has obligated $18,139 on SPE2DR26FXQ1T.
Is contract SPE2DR26FXQ1T an order under another contract?
Yes. SPE2DR26FXQ1T is a delivery order under SPE2DR25D6029, an indefinite delivery contract.
Was contract SPE2DR26FXQ1T competed?
The extent of competition for SPE2DR26FXQ1T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award